SanReno Therapeutics - Ownership and Business Overview

Life ScienceCompany

SanReno Therapeutics Ownership

Who owns SanReno Therapeutics?

SanReno Therapeutics is owned by Novartis AG. It was acquired on January 5, 2024.

SanReno Therapeutics Business Overview

Where is SanReno Therapeutics headquartered?

SanReno Therapeutics is headquartered in Shanghai, China.

What sector is SanReno Therapeutics in?

SanReno Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 96 acquisitions of life science companies in 2024, including 7 acquisitions by private equity firms, and 89 by strategics.

SanReno Therapeutics

SanReno Therapeutics (Shanghai) Ltd.

Shanghai,
China,
400-883-0816
www.sanreno.com

SanReno Therapeutics is a clinical-stage enterprise specializing in the strategic development, exploration, and commercialization of revolutionary therapies tailored for kidney diseases. The company's key assets focus on treating Immunoglobulin A Nephropathy (IgAN). Atrasentan, an oral endothelian A receptor antagonist (ERA), has reached Phase 3 with success in reducing proteinuria. Zigakibart, its anti-APRIL (A Proliferation Inducing Ligand) antibody, received regulatory approval for Phase 3 studies. SanReno Therapeutics is based in Shanghai.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for SanReno Therapeutics

Life Science Companies , China Companies